Analyst consensus rating
Caribou Biosciences Analyst Rating: Hold
Direct answer
Caribou Biosciences's consensus rating is Hold.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $5.00.
Forecast evidence checked November 22, 2026.
Get free Caribou Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.28
- Average price target
- $5.00
- High price target
- $13.00
- Low price target
- $1.00
- Low target gap
- +251.7%
- Target upside
- +1,658.7%
- High target gap
- +4,472.6%
- Target range width
- 4,220.9%
- Consensus rating
- Hold
- Analysts
- 3
- Evidence date
- November 22, 2026
- Valid through
- November 29, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Caribou Biosciences?
Caribou Biosciences has a verified Hold consensus. The same dataset has an average price target of $5.00.
How far are Caribou Biosciences's low and high targets from the recorded price?
The low target implies +251.7%, while the high target implies +4,472.6%.
How many analysts are included in Caribou Biosciences's consensus?
The verified consensus includes 3 analysts.
How is Caribou Biosciences's target upside or downside calculated?
The average target of $5.00 is divided by the recorded price of $0.28, then one is subtracted to produce +1,658.7%. This does not guarantee a future return.
When was Caribou Biosciences's analyst forecast verified?
The data was verified on 2026-11-22. The dataset is valid through 2026-11-29.